Synovics Pharmaceuticals Statistics
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
SYVC has 36.49 million shares outstanding.
| Current Share Class | 36.49M |
| Shares Outstanding | 36.49M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +4.27% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.00 |
| PB Ratio | -0.00 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 0.00 |
| P/OCF Ratio | 0.00 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.27
| Current Ratio | 0.27 |
| Quick Ratio | 0.10 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | 3.46 |
| Interest Coverage | -6.10 |
Financial Efficiency
Return on equity (ROE) is -314.28% and return on invested capital (ROIC) is -29.85%.
| Return on Equity (ROE) | -314.28% |
| Return on Assets (ROA) | -12.75% |
| Return on Invested Capital (ROIC) | -29.85% |
| Return on Capital Employed (ROCE) | -354.05% |
| Weighted Average Cost of Capital (WACC) | 9.64% |
| Revenue Per Employee | 123,171 |
| Profits Per Employee | -32,543 |
| Employee Count | 155 |
| Asset Turnover | 0.90 |
| Inventory Turnover | 6.48 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 166.44 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 53.86 |
| Average Volume (20 Days) | 10,410 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SYVC had revenue of 19.09 million and -5.04 million in losses. Loss per share was -0.18.
| Revenue | 19.09M |
| Gross Profit | 4.47M |
| Operating Income | -4.32M |
| Pretax Income | -5.04M |
| Net Income | -5.04M |
| EBITDA | -3.64M |
| EBIT | -4.32M |
| Loss Per Share | -0.18 |
Balance Sheet
The company has 129,860 in cash and 6.15 million in debt, with a net cash position of -6.02 million or -0.16 per share.
| Cash & Cash Equivalents | 129,860 |
| Total Debt | 6.15M |
| Net Cash | -6.02M |
| Net Cash Per Share | -0.16 |
| Equity (Book Value) | -773,033 |
| Book Value Per Share | -0.06 |
| Working Capital | -12.87M |
Cash Flow
In the last 12 months, operating cash flow was 1.99 million and capital expenditures -212,916, giving a free cash flow of 1.77 million.
| Operating Cash Flow | 1.99M |
| Capital Expenditures | -212,916 |
| Free Cash Flow | 1.77M |
| FCF Per Share | 0.05 |
Margins
Gross margin is 23.39%, with operating and profit margins of -22.62% and -26.42%.
| Gross Margin | 23.39% |
| Operating Margin | -22.62% |
| Pretax Margin | -26.42% |
| Profit Margin | -26.42% |
| EBITDA Margin | -19.09% |
| EBIT Margin | -22.62% |
| FCF Margin | 9.29% |
Dividends & Yields
SYVC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -84.15% |
| Shareholder Yield | -84.15% |
| Earnings Yield | -138,235.98% |
| FCF Yield | 48,624.58% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 30, 2001. It was a reverse split with a ratio of 0.2.
| Last Split Date | May 30, 2001 |
| Split Type | Reverse |
| Split Ratio | 0.2 |
Scores
SYVC has an Altman Z-Score of -6.7 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.7 |
| Piotroski F-Score | 3 |